
Can pathologic complete response (pCR) be used as a surrogate marker of survival after neoadjuvant therapy for breast cancer?
Wang-Lopez, Qian, Chalabi, Nassera, Abrial, Catherine, Radosevic-Robin, Nina, Durando, Xavier, Mouret-Reynier, Marie-Ange, Benmammar, Kheir-Eddine, Kullab, Sharif, Bahadoor, Mohun, Chollet, Philippe,Volume:
95
Langue:
english
Journal:
Critical Reviews in Oncology/Hematology
DOI:
10.1016/j.critrevonc.2015.02.011
Date:
July, 2015
Fichier:
PDF, 275 KB
english, 2015